ALS TDI to Convene ALS Research, Industry, and Community Leaders at 2026 Summit and White Coat Affair Gala

This October, two Boston events will bring people together to share research updates, build connections, and accelerate progress for people with ALS. [PR.com]

Posted on: 23 September 2026 | 7:40 am

SignaBlok Awarded NIH NIDDK Grant to Develop Novel TREM-1 Antagonist Drug for Inflammatory Bowel Disease

SignaBlok, Inc. has been awarded a Phase I SBIR grant from the NIH NIDDK to advance the development of a novel mechanism-based therapy for inflammatory bowel disease (IBD). The award supports SignaBlok's differentiated approach to targeting TREM-1 in IBD. [PR.com]

Posted on: 18 September 2026 | 2:00 am

Rob Merrill Named CEO of TFives, Life Sciences AI Compliance

TFives appoints 25-year healthcare regulatory veteran as CEO to lead enterprise adoption of compliance-ready AI governance for the Life Sciences industry. [PR.com]

Posted on: 17 September 2026 | 8:58 pm

Microvascular Therapeutics Appoints George Kokke to Board of Directors

Veteran family office executive and healthcare investor brings more than 30 years of investment, finance, and board experience. [PR.com]

Posted on: 17 September 2026 | 7:00 am

MVT Nanobubbles Enable Non-Thermal Focused Ultrasound Ablation in Preclinical Brain Tumor Study

University of Utah researchers use MVT-101 phase-shift nanobubbles with focused ultrasound and MRI to confirm treatment location [PR.com]

Posted on: 14 September 2026 | 7:00 am

Microvascular Therapeutics Appoints Charles Garrison, MD, to Scientific Advisory Board

Dr Charles Garrison, an experienced pathologist, biotechnology entrepreneur, and life sciences investor will advise MVT on scientific and medical development as new Scientific Advisory Board member. [PR.com]

Posted on: 14 September 2026 | 7:00 am

Kepon Biotech Addresses Global Biopharma Supply‑Chain Pain Points with China‑Based One‑Stop Procurement System

Kepon Biotech is a Chinese one‑stop supply‑chain partner for life‑science clients. It resolves procurement challenges: scattered suppliers, complex cross‑border compliance, variable batch quality and long lead‑times. It provides consolidated sourcing, special‑goods compliance, graded cold‑chain logistics and global certifications for cell lines, culture media, LAL reagents and clinical materials, delivering [PR.com]

Posted on: 7 September 2026 | 8:26 am

Asclepii Selected to Exhibit Poseidon at Vizient Innovative Technology Exchange

Asclepii will showcase its FDA 510(k)-cleared Poseidon™ Nanosilver Hydrogel at Vizient’s Innovative Technology Exchange in Las Vegas on September 24, marking an important milestone in the company’s commercial expansion and bringing its wound care technology to healthcare leaders across Vizient’s network. [PR.com]

Posted on: 4 September 2026 | 2:00 am

Helix BioMedix Completes $2 Million Private Placement to Advance Xeroderma Pigmentosum Development Program

Financing strengthens balance sheet and accelerates advancement of proprietary DNA repair technology targeting UV-induced DNA damage. [PR.com]

Posted on: 29 August 2026 | 2:00 am

VMRD Launches Rapid Horse-Side Insulin Test to Decrease Risk of Laminitis in Metabolic Horses

VMRD, Inc. is thrilled to share the launch of their exciting new test for horse-side measurement of insulin in horses. Run on the same palm-sized reader as VMRD SAA and Foal IgG, this highly portable multi-functional testing platform embodies VMRD’s vision of improving animal health through high-quality, practical diagnostics. Equine Metabolic Syndrome and insulin dysregulation are incredibly common in the equine [PR.com]

Posted on: 28 August 2026 | 6:02 am

Kepon Biotech Launches Integrated Cross‑Border Risk‑Control Solutions for Global Cell Culture Media Trade

Kepon Biotech handles import‑export for fermentation, research and GMP clinical‑grade cell culture media. It addresses cross‑border risks such as bioactivity degradation, complex global regulations and customs detention. With EAC, REACH, FDA, TGA, PMDA, CMDCAS and Halal credentials, it delivers grade classification, global certification, light‑shielded cold‑chain logistics and multilingual customs documents for [PR.com]

Posted on: 19 August 2026 | 10:23 am

Kepon Biotech Launches Integrated Cross‑Border Solutions for Global Spermidine Procurement

Kepon Biotech provides multi‑grade spermidine and spermidine trihydrochloride for food, pharma, cosmetics and life‑science research. It mitigates cross‑border risks such as oxidative degradation, complex certification rules and HS misclassification. Backed by EAC, REACH, FDA and Halal credentials, it delivers one‑stop certification, nitrogen‑sealed temperature‑controlled logistics and multilingual customs [PR.com]

Posted on: 19 August 2026 | 10:20 am

Kepon Biotech Launches One-Stop Cross-Border Compliance & Logistics Solutions for Life Science Reagents

Kepon Biotech provides a one-stop global compliance and supply system for life science procurement. It solves core cross-border challenges including complex customs clearance, unstable cold-chain logistics, fragmented regional regulations. The company offers standardized biochemical reagents, reference standards and cell culture media, with full compliance support and segmented temperature-controlled logistics, delivering [PR.com]

Posted on: 19 August 2026 | 10:05 am

Kepon Biotech Launches Integrated Cross‑Border Export Solutions for Global LAL Endotoxin‑Testing Reagent Procurement

Kepon Biotech delivers factory‑sourced LAL endotoxin‑testing kits for biopharma, vaccine and medical‑device clients. Working with ISO13485‑certified manufacturers, it provides regional compliance paperwork, 2‑8°C cold‑chain logistics and low‑MOQ trial orders across CIS, Southeast Asia, Middle East, EU and North America. Its one‑stop export solution fixes customs detention, reagent deactivation and [PR.com]

Posted on: 18 August 2026 | 10:26 am

Kepon Biotech Unveils Full-Link Risk Control & Compliance Solutions for Global Cell Culture Media Trade

Global labs and biopharma firms encounter common cell culture media procurement risks: inconsistent batches, customs delays, cold chain product inactivation and inflexible high MOQs. Shanghai Kepon Biotech releases a full cross-border supply solution and procurement risk guide, offering flexible samples, one-stop biological goods clearance and segmented cryogenic logistics for global cell research, biotech and diagnostic [PR.com]

Posted on: 18 August 2026 | 9:56 am

Kepon Biotech Launches Comprehensive Cross-Border Procurement & Risk Control Solutions for Industrial Fine Chemicals

Global factories, energy plants and research labs run into widespread procurement risks for industrial chemicals: inconsistent purity, hazardous goods customs blockages, failed long-distance shipping, rigid high MOQs and incomplete compliance documents. Shanghai Kepon Biotech releases an integrated cross-border supply system and complete pitfall guide, providing flexible trial orders, one-stop chemical customs agency and [PR.com]

Posted on: 17 August 2026 | 3:23 am

Kepon Biotech Launches Integrated Cross-Border Procurement and Risk Control Solutions for High-Purity Organic & Inorganic Chemicals

Global labs and pharma face organic & inorganic chemical procurement risks including unstable purity, customs detention, failed shipping, high MOQs and incomplete SDS docs. Shanghai Kepon Biotech releases a cross-border supply & risk guide with flexible samples, full chemical clearance and custom cold chain logistics for life science and new energy industries. [PR.com]

Posted on: 17 August 2026 | 3:22 am

Shanghai Kepon Biotech Launches Full Risk-Control Cross-Border Solutions for Certified Reference Standards Procurement

Global labs, pharma and food testers face China reference standards cross-border risks: poor batch traceability, customs delays, rigid MOQs, cold chain breakdowns and missing COA/SDS. Shanghai Kepon Biotech offers integrated supply, special goods clearance and segmented cold chain for life science, new energy and food testing industries. [PR.com]

Posted on: 17 August 2026 | 3:13 am

Food Safety Standards Raw Material Procurement Solutions & Risk Avoidance Guide Released by Shanghai Kepon Biotech for Global Food Testing & Food Manufacturing Plants

Global food manufacturers and third-party food testing labs face severe procurement risks for food safety reference standards: inconsistent batch purity, cross-border food regulatory document gaps, strict customs inspection, high MOQ limits and incomplete compliance certification. Shanghai Kepon Biotech launches integrated cross-border supply system, one-stop food safety filing and traceable certified standards for food [PR.com]

Posted on: 16 August 2026 | 6:51 am

New 2026 Report Reveals an AI/LLM Gap Between Biopharma Sponsors and Their CROs/Vendors

Life Science Strategy Group looks beyond frontier-AI hype to show how biopharma teams use AI and LLMs in daily work, and where their CRO and vendor partners are falling short. 71% of sponsors rate their own AI/LLM output highly. Only 27% say the same of their CROs and vendors. [PR.com]

Posted on: 12 August 2026 | 8:00 am

DNA Harvest Partners and ToolGen Announce Strategic Partnership to Accelerate AI-Guided Predictive Breeding for Gene-Edited Crops

DNA Harvest Partners Pte. Ltd. (DNAHP), one of the world's most advanced AI-guided predictive breeding companies, and ToolGen, a global leader in CRISPR-Cas9 gene editing technology, today announced a strategic partnership to accelerate the development of superior rapeseed (Brassica napus) varieties through the integration of artificial intelligence-driven predictive breeding with cutting-edge genome editing. Under the [PR.com]

Posted on: 11 August 2026 | 7:27 am

ecotera health Submits Decentralized Urine Microplastics / Nanoplastics Observational Study for IRB Review

Study will evaluate an at-home approach to longitudinal microplastics / nanoplastics monitoring in urine using the EcoExposure™ platform [PR.com]

Posted on: 8 August 2026 | 2:00 am

New York Cancer & Blood Specialists Welcomes Hematologist-Oncologist Dr. David Drory

New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, proudly announces the addition of Dr. David Drory to its team of dedicated medical oncologists and hematologists. Beginning August 3, 2026, Dr. Drory will be practicing at NYCBS’s office located at 50 N Park Avenue, 2nd Floor, Rockville Centre, NY 11570. “We are excited to welcome Dr. Drory to our [PR.com]

Posted on: 4 August 2026 | 2:00 am

Microvascular Therapeutics Highlights the Future of Ultrasound Theranostics in Comprehensive Wiley Review

Microvascular Therapeutics, Inc. (MVT) today announced publication of a comprehensive review in Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (WIREs Nanomedicine and Nanobiotechnology), a leading peer-reviewed journal with a 2025 Journal Impact Factor of 8.6, entitled, "Development of Ultrasound Microbubbles and Phase Shift Microbubbles in Theranostics." The review, authored by Emmanuelle [PR.com]

Posted on: 28 July 2026 | 6:40 am

New York Cancer & Blood Specialists Opens New State-of-the-Art Cancer Center in Lake Success

New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, is proud to announce the opening of its new comprehensive cancer center at 3 Dakota Drive, Lake Success, NY 11042. The location will open to patients on July 13, 2026, and replaces its previous nearby site at 1 Delaware Drive. “Our facility represents a significant step forward in our mission to deliver [PR.com]

Posted on: 10 July 2026 | 11:53 am